Joseph Wazen, DO
Sports Medicine · Hanover, MDNPI 1487158952
Payments from drug & device makers
What this record shows
Stryker accounts for 70.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $4,327 and has fallen 70.2% since, to $1,290 in 2025.
Across 67 payments — averaging $94.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Arthrex$1K
- Pylant Medical$210
- Pacira Pharmaceuticals Incorporated$123
- Smith+Nephew$121
- Native Surgical, LLC$120
- plus $123 from 3 others
What the payments were for
- Travel & lodging$3,30352%
- Food & beverage$3,04748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 39 | $4,461 |
| Arthrex | 18 | $1,193 |
| Pylant Medical | 2 | $210 |
| Pacira Pharmaceuticals Incorporated | 1 | $123 |
| Smith+Nephew | 2 | $121 |
| Native Surgical, LLC | 2 | $120 |
| Supreme Orthopedic Systems, LLC | 1 | $56 |
| Paladin Technology Solutions | 1 | $36 |
| Reel Surgical, Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,074
- ICONIX$944
- AEQUALIS PERFORM$750
- AEQUALIS PERFORM REVERSED$297
- HOFFMANN$170
- MAKO$163
- TRIDENT$163
- AEQUALIS ASCEND FLEX$151
- AXSOS$126
- Iovera$123
How this compares
$6,351 in reported general payments places this provider in the 75th percentile of 111 sports medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 16 | $26 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Hanover
- Emmanuel KoliHanover$23K
- Garrett LynchAnnapolis$1.4M
- Raymond ThalBethesda$779K
- Jason ScoppSalisbury$637K
- John ChristoforettiBethesda$418K
- Jonas RudzkiChevy Chase$386K
- Matthew LevineFrederick$364K
- Abdulaziz AhmedBaltimore$85K
- Taylor WileySalisbury$53K
- Jason HammondBaltimore$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.